advertisement
ATC Level5: C09CA08 - Olmesartan Medoxomil
ATC Level1:
- C - Cardiovascular system
ATC Level2:
- C09 - Agents acting on the renin
ATC Level3:
- C09C - Angiotensin II antagonists, plain
ATC Level4:
- C09CA - Angiotensin II antagonists, plain
ATC Level5:
- C09CA08 - Olmesartan Medoxomil
Drugs in ATC category "C09CA08":
- Almetec
- Pharmacological action Almetec is an antihypertensive agent, angiotensin II receptor blocker. This medication has a high selectivity to angiotensin II receptor type 1 (AT1) which are implemented with the participation of the main effects of angiotensin II. By blocking these receptors olmesartan medoxomil prevents and eliminates the vasoconstrictor action of angiotensin II, causes a secondary increase in plasma renin activity due to elimination of negative feedback for renin release and a...
- Alteis
- Pharmacological action Alteis is an antihypertensive agent, angiotensin II receptor blocker. This medication has a high selectivity to angiotensin II receptor type 1 (AT1) which are implemented with the participation of the main effects of angiotensin II. By blocking these receptors olmesartan medoxomil prevents and eliminates the vasoconstrictor action of angiotensin II, causes a secondary increase in plasma renin activity due to elimination of negative feedback for renin release and a...
- Alzor
- Pharmacological action Alzor is an antihypertensive agent, angiotensin II receptor blocker. This medication has a high selectivity to angiotensin II receptor type 1 (AT1) which are implemented with the participation of the main effects of angiotensin II. By blocking these receptors olmesartan medoxomil prevents and eliminates the vasoconstrictor action of angiotensin II, causes a secondary increase in plasma renin activity due to elimination of negative feedback for renin release and a...
- Benetor
- Benicar
- Olmesartan is used to treat high blood pressure ( hypertension ). Lowering high blood pressure helps prevent strokes, heart attacks , and kidney problems. Olmesartan belongs to a class of drugs called angiotensin receptor blockers. It works by relaxing blood vessels so that blood can flow more easily. OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional....
- Benitec
- Pharmacological action Benitec is an antihypertensive agent, angiotensin II receptor blocker. This medication has a high selectivity to angiotensin II receptor type 1 (AT1) which are implemented with the participation of the main effects of angiotensin II. By blocking these receptors olmesartan medoxomil prevents and eliminates the vasoconstrictor action of angiotensin II, causes a secondary increase in plasma renin activity due to elimination of negative feedback for renin release and a...
- Cardioplus
- Ixia
- Olmat
- Olmax
- Olmec
- Olmecip
- Olmefast
- Pharmacological action Olmefast is an antihypertensive agent, angiotensin II receptor blocker. This medication has a high selectivity to angiotensin II receptor type 1 (AT1) which are implemented with the participation of the main effects of angiotensin II. By blocking these receptors olmesartan medoxomil prevents and eliminates the vasoconstrictor action of angiotensin II, causes a secondary increase in plasma renin activity due to elimination of negative feedback for renin release and a...
- Olmes
- Olmesar
- Pharmacological action Olmesar is an antihypertensive agent, angiotensin II receptor blocker. This medication has a high selectivity to angiotensin II receptor type 1 (AT1) which are implemented with the participation of the main effects of angiotensin II. By blocking these receptors olmesartan medoxomil prevents and eliminates the vasoconstrictor action of angiotensin II, causes a secondary increase in plasma renin activity due to elimination of negative feedback for renin release and a...
- Olmesartan (Olmesartan)
- Olmesartan is an antihypertensive agent which belongs to the class of medicines called angiotensin II receptor antagonists. It acts rapidly to lower high blood pressure. It is marketed worldwide by Daiichi Sankyo, Ltd. and in the United States by Daiichi Sankyo, Inc. and Forest Laboratories. Indication: For the treatment of hypertension. Olmesartan, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin...
- Olmesartan (Olmesartan Medoxomil)
- Olmesartan is an antihypertensive agent which belongs to the class of medicines called angiotensin II receptor antagonists. It acts rapidly to lower high blood pressure. It is marketed worldwide by Daiichi Sankyo, Ltd. and in the United States by Daiichi Sankyo, Inc. and Forest Laboratories. Indication: For the treatment of hypertension. Olmesartan, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin...
- Olmetec
- Olmesartan belongs to the class of medications called angiotensin II receptor blockers. It is used to reduce blood pressure by blocking the actions of a chemical ( angiotensin II ) that causes blood vessels to constrict or tighten. It is used to treat mild to moderate high blood pressure. Your blood pressure may start to decrease within 1 to 2 weeks of starting this medication. When blood pressure is allowed to remain high for a long time, the blood vessels of the heart, kidneys, and...
- Olmetor
- Olmezar
- Olmezest
- Olmighty
- Olmy
- Olmy-R
- Olsar
- Olvance
- Omesar
- Openvas
- Oukat
- Pharmacological action Oukat is an antihypertensive agent, angiotensin II receptor blocker. This medication has a high selectivity to angiotensin II receptor type 1 (AT1) which are implemented with the participation of the main effects of angiotensin II. By blocking these receptors olmesartan medoxomil prevents and eliminates the vasoconstrictor action of angiotensin II, causes a secondary increase in plasma renin activity due to elimination of negative feedback for renin release and a...
- Pinom
- Tensonit
- Votum
- Win-BP
- Zoltab
advertisement
The information was verified by Dr. Rachana Salvi, MD Pharmacology
© 2002 - 2024 "sdrugs.com". All Rights Reserved